Area of research
Oncology · Molecular Biology
Research interest
Research interests include Clusterin in disease pathology, Estrogen and related hormone effects, Glycosylation and Glycoproteins Research, and Epigenetics and DNA Methylation.
Multicenter evaluation of label-free quantification in human plasma on a high dynamic range benchmark set
Re-epithelialization of cancer cells increases autophagy and DNA damage: Implications for breast cancer dormancy and relapse
Selective arm-usage of pre-miR-1307 dysregulates angiogenesis and affects breast cancer aggressiveness
PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and Tamoxifen in a luminal A breast cancer model
Inducible re-epithelialization of cancer cells increases autophagy and DNA damage: implications for breast cancer dormancy
Lysis buffer selection guidance for mass spectrometry-based global proteomics including studies on the intersection of signal transduction and metabolism
Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targets
Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targets
Erythropoietin-driven dynamic proteome adaptations during erythropoiesis prevent iron overload in the developing embryo
Cell-to-cell variability in JAK2/STAT5 pathway components and cytoplasmic volumes defines survival threshold in erythroid progenitor cells
The ParaHox gene Cdx4 induces acute erythroid leukemia in mice
Cell-to-cell variability in JAK2/STAT5 pathway components and cytoplasmic volumes define survival threshold in erythroid progenitor cells